BiotechTube
Efferent Labs

Efferent Labs

Plymouth, United States· Est.
efferentlabs.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

Efferent Labs is a private, pre-revenue medical device and diagnostics company founded in 2015 and headquartered in Plymouth, USA. The company is developing a proprietary platform for continuous, real-time monitoring and management of bodily fluids, targeting significant unmet needs in critical care, heart failure, and sepsis management. By translating fluid dynamics into actionable clinical data, Efferent aims to enable more precise and proactive interventions, potentially reducing complications and hospital stays. The company appears to be in the development and prototyping stage, advancing its core technology toward clinical validation and regulatory pathways.

Critical CareCardiologyNephrologySepsis

Technology Platform

Proprietary platform for continuous, real-time monitoring and management of bodily fluids, utilizing sensors and integrated systems to provide quantitative data on fluid status.

Funding History

2
Total raised:$15M
Series A$12M
Seed$3M

Opportunities

The large and growing market for hemodynamic and fluid status monitoring, driven by an aging population and rising rates of sepsis and heart failure, presents a significant opportunity.
The shift towards data-driven, personalized medicine in hospital settings creates a strong tailwind for innovative diagnostic devices that integrate into clinical workflows.
Efferent's focus on a high-need, poorly addressed clinical problem could facilitate rapid adoption if clinical utility and cost-effectiveness are demonstrated.

Risk Factors

The company faces substantial technical risk in developing a reliable and accurate sensor system, and regulatory risk in obtaining FDA clearance for a novel device.
As a pre-revenue startup, it is highly dependent on external funding and faces significant competition from large, established medical device companies with extensive sales networks and resources.

Competitive Landscape

Efferent operates in a competitive space with large incumbents like Edwards Lifesciences (hemodynamic monitoring) and Baxter (fluid management systems), as well as other startups exploring digital biomarkers and remote monitoring. Its differentiation hinges on the specificity, continuity, and clinical actionability of its fluid data, aiming to offer a more direct and comprehensive solution than current intermittent or proxy measurements.

More companies in Digital Health & Biotech SaaS →More companies in United States →